Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products

by Sphere Fluidics | Jan 24, 2017 | News Cambridge, UK, 24th January 2017: Sphere Fluidics Limited (SF), an established Life Sciences tools company, today announced the launch of their new E-Commerce website platform to enable researchers easy access to its specialist microfluidic products. The new website functionality allows scientists rapid, global access to a patented range of specialist chemicals, microfluidic biochips... Read more

One of the World’s fastest metals analyser Vulcan, launched by Oxford Instruments

One of the World’s fastest metals analyser Vulcan, launched by Oxford Instruments 24 January 2017 Oxford Instruments has launched Vulcan, one of the fastest metals analyser with advanced reporting tools on the market. Vulcan is an ergonomic, balanced handheld LIBS (Laser Induced Breakdown Spectroscopy) analyser with a simple user interface. Vulcan has been designed for... Read more

Enzo Life Sciences Launches New Compound Library to Provide Essential Standards for Cancer Inhibitor Screening

Enzo Life Sciences is proud to introduce the SCREEN-WELL® Cancer Library, a collection of 275 ready-to-use compounds for use in cancer inhibitor screening and assay development. The SCREEN-WELL® Cancer Library is comprised of compounds that are dissolved at 10 mM in DMSO and aliquoted at 100 µL per well in deep 96-well plates. It contains... Read more

Gyros Protein Technologies appoints Gerrit van den Dool to Board of Directors

Uppsala, Sweden, 19 January 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in the life science industry and with his... Read more

908 Devices Strengthens Life Science Leadership Team and Unveils Transformational Advancements to ZipChip

01.18.17 Life Sciences 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecule analysis, today announced significant product enhancements for ZipChip™, an innovative system that provides high-quality separation capabilities as a front-end for mass spectrometry (MS). An integrated autosampler, built-in chip recognition intelligence and application specific assay kits are being released to radically... Read more

Neogen develops superior chromogenic media for Salmonella

CONTACT: Joanne McPeake, Neogen Europe Ltd., +44 (0) 1292 525 600 AYR, Scotland, 18 January, 2017 — Neogen’s Lab M has developed a unique chromogenic media that offers a superior ability to simultaneously detect numerous strains of Salmonella of concern to the food and animal feed industries, while inhibiting or minimizing other organisms. This new... Read more

Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau

WARREN, N.J., Jan. 17, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced the appointment of Mary Duseau as President and CEO.  Ms. Duseau succeeds Paul Thomas, the Company’s President and CEO since 2009, who will assume the... Read more

Congenica Expands in North America with Strategic Appointment

Congenica Expands in North America with Strategic Appointment Shikha O’Brien, Chief Business Officer Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer 16th January 2017, Cambridge UK Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha... Read more

Smiths Group welcomes European Commission clearance for acquisition of Morpho Detection

19 Jan 2017 Smiths Group plc (“Smiths Group”) welcomes the European Commission’s clearance of the proposed acquisition of Morpho Detection. In order to secure approval in Phase I of the EU merger review process, Smiths Group proposed the divestment of Morpho Detection’s explosive trace detection (“Trace”) business. This divestment is conditional on the successful closing... Read more